ORC6 and central nervous system cancer: Analysis from the Chinese Glioma Genome Atlas (CGGA) database underscores that glioma patients exhibiting heightened ORC6 expression (n = 307) tend to have lower survival rates than those with low ORC6 expression (n = 307) (P < 0.001, Fig. 2D).